SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The revenue zoomed 7.11% to Rs. 14386.30 millions for the quarter ended March 2024 as compared to Rs. 13430.80 millions during the corresponding quarter last year.A humble growth in net profit of 24.04% reported in the quarter ended March 2024 to Rs. 2870.60  millions from Rs. 2314.20 millions.OP of the company witnessed a marginal growth to 4106.80 millions from 3297.60 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 14386.30 13430.80 7.11 58489.10 53487.30 9.35 58489.10 53487.30 9.35
Other Income 811.50 496.40 63.48 2482.70 1541.50 61.06 2482.70 1541.50 61.06
PBIDT 4106.80 3297.60 24.54 17013.70 13597.80 25.12 17013.70 13597.80 25.12
Interest 28.10 40.10 -29.93 124.50 159.90 -22.14 124.50 159.90 -22.14
PBDT 4078.70 3257.50 25.21 16889.20 13437.90 25.68 16889.20 13437.90 25.68
Depreciation 181.90 173.40 4.90 711.70 699.70 1.72 711.70 699.70 1.72
PBT 3896.80 3084.10 26.35 16177.50 12738.20 27.00 16177.50 12738.20 27.00
TAX 1026.20 769.90 33.29 4165.30 3244.10 28.40 4165.30 3244.10 28.40
Deferred Tax 67.90 35.40 91.81 10.70 -11.90 -189.92 10.70 -11.90 -189.92
PAT 2870.60 2314.20 24.04 12012.20 9494.10 26.52 12012.20 9494.10 26.52
Equity 212.50 212.50 0.00 212.50 212.50 0.00 212.50 212.50 0.00
PBIDTM(%) 28.55 24.55 16.27 29.09 25.42 14.42 29.09 25.42 14.42

Abbott India Share Price

25198.45 -224.05 (-0.88%)
24-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1619.95
Dr. Reddys Lab 1315.85
Cipla 1294.75
Zydus Lifesciences 927.15
Lupin 2296.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×